Tags : Oncology Portfolio


Mylan Launches Generic Faslodex Injection for the Expansion of its

Shots: Mylan launches Fulvestrant Injection (50 mg/mL)/single-dose prefilled syringe which is a generic version of AstraZeneca’s Faslodex Injection and has received FDA’s ANDA as monothx. for advanced BC in women with menopause and combination therapy for advance & m-BC The launch of Fulvestrant Injection expands Mylan’s oncology portfolio and available treatment options for women facing […]Read More